Early induced therapeutic hypothermia represents the cornerstone treatment in neonates
with probable hypoxic-ischemic encephalopathy. The selection of patients for treatment …

Background The ability to determine severity of encephalopathy is crucial for early
neuroprotective therapies and for predicting neurodevelopmental outcome. The objective of …

Background Therapeutic hypothermia (TH) is routinely provided to those with moderate or
severe neonatal encephalopathy (NE). Subtle differences exist in the standardized exams …

Background Neonatal encephalopathy (NE) continues to be a significant risk for death and
disability. To address this risk, regional guidelines were developed with the support of a …

Objective This study aimed to describe the evolution of amplitude-integrated
electroencephalography (aEEG) in neonatal encephalopathy (NE) during therapeutic …

It has been over a decade since therapeutic hypothermia (TH) was shown in multiple large
randomized controlled trials to improve the survival without disability after moderate-to …

Objective To describe patterns of renal and hepatic injury in infants with hypoxic ischemic
encephalopathy (HIE). Study design Retrospective cohort of infants receiving therapeutic …

Neonatal encephalopathy occurs in 2 to 6/1000 live births and is principally related to
hypoxic-ischemic injury to the newborn brain in the immediate peripartum period. In the first …

Objective To study the association between the Sarnat exam (SE) performed before and
after therapeutic hypothermia (TH) and outcomes at 2 years in infants with moderate or …

La hipoxia isquemia perinatal y su complicación más temida, la encefalopatía hipóxica
isquémica, continúa siendo uno de los principales motivos de ingreso a las unidades de …